Guided Therapeutics (GTHP) Change in Receivables (2011 - 2025)
Guided Therapeutics' (GTHP) quarterly Change in Receivables came in at $8000.0 in Q2 2025, up 366.67% year-on-year from $1714.3 in Q2 2024, and up 900.0% quarter-over-quarter from -$1000.0 in Q1 2025.
Guided Therapeutics (GTHP) Change in Receivables (2011 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Change in Receivables across 15 years of filings, most recently posting $8000.0 for Q2 2025.
- Change in Receivables for Q2 2025 came in at $8000.0, up 366.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $7000.0 (up 216.67% YoY), and the FY2025 annual result was $7000.0, up 216.67% from the prior year.
- Change in Receivables came in at $8000.0 for Q2 2025 at Guided Therapeutics, up from -$1000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $22000.0 in Q4 2021 to a low of -$32000.0 in Q3 2022.
- The 5-year median for Change in Receivables is -$1000.0 (2023), against an average of $769.23.
- Peak annual rise in Change in Receivables reached 600.0% in 2022, while the deepest fall reached 1700.0% in 2022.
- Guided Therapeutics' Change in Receivables stood at $22000.0 in 2021, then plunged by 245.45% to -$32000.0 in 2022, then jumped by 112.5% to $4000.0 in 2023, then slumped by 150.0% to -$2000.0 in 2024, then jumped by 500.0% to $8000.0 in 2025.
- The last three Change in Receivables figures came in at $8000.0 (Q2 2025), -$1000.0 (Q1 2025), and -$2000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Mar 31, 2022 | 6,000.00 |